International Clinical Trial: A Randomized, Double-blind, Placebo-controlled, Single-ascending-dose Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SV003 in Healthy Participants

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07469085) titled 'A Randomized, Double-blind, Placebo-controlled, Single-ascending-dose Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SV003 in Healthy Participants' on March 9.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Shanghai Synvida Biotechnology Co.,Ltd.

Condition: Healthy Participants

Intervention: Drug: SV003

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: March 31, 2026

Target S...